{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:59:05Z","timestamp":1791831545164,"version":"4.3.4"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK111052"],"award-info":[{"award-number":["DK111052"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570300"],"award-info":[{"award-number":["81570300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Humans and rodents with Comparative Gene Identification-58 (CGI-58) mutations manifest nonalcoholic fatty liver disease (NAFLD). Here we show that liver CGI-58 knockout (LivKO) mice fed a Western diet rapidly develop advanced NAFLD, including nonalcoholic steatohepatitis (NASH) and hepatic fibrosis. After 14 weeks of diet challenge, starting at 6 weeks of age, LivKO mice showed increased inflammatory cell infiltration and proinflammatory gene expression in the liver, which was associated with elevated plasma levels of aminotransferases. Hepatic ductular reactions, pericellular fibrosis, and bridging fibrosis were observed only in the LivKO mice. Consistently, the KO mice had a significant increase in hepatic mRNAs for fibrogenic genes. In addition, LivKO mice displayed massive accumulation of lipid droplets (LDs) in hepatocytes. LDs were also observed in the cholangiocytes of the LivKO mice, but not the floxed controls. Four of the five LD coat proteins, including perilipins 2, 3, 4, and 5, were increased in the CGI-58 KO liver. CRISPR\/Cas9-mediated knockout of CGI-58 in Huh7 human hepatoma cells induced LD deposition and perilipin expression, suggesting a cell autonomous effect. Our findings establish the Western diet-fed LivKO mice as an animal model of NASH and hepatic fibrosis. These animals may facilitate preclinical screening of therapeutic agents that counter against NAFLD progression.<\/jats:p>","DOI":"10.1038\/s41598-020-61473-6","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T11:03:25Z","timestamp":1584097405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice"],"prefix":"10.1038","volume":"10","author":[{"given":"Pan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"key":"61473_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384, https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatology"},{"key":"61473_CR2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","volume":"332","author":"JC Cohen","year":"2011","unstructured":"Cohen, J. C., Horton, J. D. & Hobbs, H. H. Human fatty liver disease: old questions and new insights. Sci. 332, 1519\u20131523 (2011).","journal-title":"Sci."},{"issue":"6","key":"61473_CR3","doi-asserted-by":"publisher","first-page":"524-530.e1","DOI":"10.1016\/j.cgh.2011.03.020","volume":"9","author":"Zobair M. Younossi","year":"2011","unstructured":"Younossi, Z. M. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9, 524\u2013530 e521, quiz e560, https:\/\/doi.org\/10.1016\/j.cgh.2011.03.020 (2011).","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"61473_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day, C. P. & James, O. F. Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology 114, 842\u2013845 (1998).","journal-title":"Gastroenterology"},{"key":"61473_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung, C., Rivera, L., Furness, J. B. & Angus, P. W. The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13, 412\u2013425, https:\/\/doi.org\/10.1038\/nrgastro.2016.85 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"61473_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53, 810\u2013820, https:\/\/doi.org\/10.1002\/hep.24127 (2011).","journal-title":"Hepatology"},{"key":"61473_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cmet.2006.03.005","volume":"3","author":"A Lass","year":"2006","unstructured":"Lass, A. et al. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab. 3, 309\u2013319 (2006).","journal-title":"Cell Metab."},{"key":"61473_CR8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1086\/324121","volume":"69","author":"C Lefevre","year":"2001","unstructured":"Lefevre, C. et al. Mutations in CGI-58, the gene encoding a new protein of the esterase\/lipase\/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am. J. Hum. Genet. 69, 1002\u20131012 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"61473_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1126\/science.1100747","volume":"306","author":"R Zimmermann","year":"2004","unstructured":"Zimmermann, R. et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Sci. 306, 1383\u20131386 (2004).","journal-title":"Sci."},{"key":"61473_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ng1951","volume":"39","author":"J Fischer","year":"2007","unstructured":"Fischer, J. et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat. Genet. 39, 28\u201330 (2007).","journal-title":"Nat. Genet."},{"key":"61473_CR11","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1194\/jlr.M035519","volume":"54","author":"F Guo","year":"2013","unstructured":"Guo, F. et al. Deficiency of liver Comparative Gene Identification-58 causes steatohepatitis and fibrosis in mice. J. Lipid Res. 54, 2109\u20132120, https:\/\/doi.org\/10.1194\/jlr.M035519 (2013).","journal-title":"J. Lipid Res."},{"key":"61473_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922, https:\/\/doi.org\/10.1038\/s41591-018-0104-9 (2018).","journal-title":"Nat. Med."},{"key":"61473_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/hep.23797","volume":"52","author":"R Kohli","year":"2010","unstructured":"Kohli, R. et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52, 934\u2013944, https:\/\/doi.org\/10.1002\/hep.23797 (2010).","journal-title":"Hepatology"},{"key":"61473_CR14","doi-asserted-by":"publisher","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","volume":"301","author":"M Charlton","year":"2011","unstructured":"Charlton, M. et al. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am. J. Physiol. Gastrointest. Liver Physiol 301, G825\u2013834, https:\/\/doi.org\/10.1152\/ajpgi.00145.2011 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"61473_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","volume":"65","author":"A Asgharpour","year":"2016","unstructured":"Asgharpour, A. et al. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J. Hepatol. 65, 579\u2013588, https:\/\/doi.org\/10.1016\/j.jhep.2016.05.005 (2016).","journal-title":"J. Hepatol."},{"key":"61473_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","volume":"69","author":"T Tsuchida","year":"2018","unstructured":"Tsuchida, T. et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J. Hepatol. 69, 385\u2013395, https:\/\/doi.org\/10.1016\/j.jhep.2018.03.011 (2018).","journal-title":"J. Hepatol."},{"key":"61473_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biochi.2004.12.010","volume":"87","author":"C Londos","year":"2005","unstructured":"Londos, C., Sztalryd, C., Tansey, J. T. & Kimmel, A. R. Role of PAT proteins in lipid metabolism. Biochim. 87, 45\u201349 (2005).","journal-title":"Biochim."},{"key":"61473_CR18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.bbalip.2017.07.009","volume":"1862","author":"C Sztalryd","year":"2017","unstructured":"Sztalryd, C. & Brasaemle, D. L. The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1862, 1221\u20131232, https:\/\/doi.org\/10.1016\/j.bbalip.2017.07.009 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"61473_CR19","doi-asserted-by":"publisher","first-page":"19146","DOI":"10.1074\/jbc.M500978200","volume":"280","author":"NE Wolins","year":"2005","unstructured":"Wolins, N. E. et al. S3-12, Adipophilin, and TIP47 package lipid in adipocytes. J. Biol. Chem. 280, 19146\u201319155 (2005).","journal-title":"J. Biol. Chem."},{"key":"61473_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.yexcr.2015.10.021","volume":"340","author":"RM Carr","year":"2016","unstructured":"Carr, R. M. & Ahima, R. S. Pathophysiology of lipid droplet proteins in liver diseases. Exp. Cell Res. 340, 187\u2013192, https:\/\/doi.org\/10.1016\/j.yexcr.2015.10.021 (2016).","journal-title":"Exp. Cell Res."},{"key":"61473_CR21","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1194\/jlr.R700014-JLR200","volume":"48","author":"DL Brasaemle","year":"2007","unstructured":"Brasaemle, D. L. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 48, 2547\u20132559 (2007).","journal-title":"J. Lipid Res."},{"key":"61473_CR22","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/hep.20130","volume":"39","author":"TA Roskams","year":"2004","unstructured":"Roskams, T. A. et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39, 1739\u20131745, https:\/\/doi.org\/10.1002\/hep.20130 (2004).","journal-title":"Hepatology"},{"key":"61473_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/hep.30150","volume":"69","author":"K Sato","year":"2019","unstructured":"Sato, K. et al. Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances. Hepatology 69, 420\u2013430, https:\/\/doi.org\/10.1002\/hep.30150 (2019).","journal-title":"Hepatology"},{"key":"61473_CR24","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel, V. T. & Shulman, G. I. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852\u2013871 (2012).","journal-title":"Cell"},{"key":"61473_CR25","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/hep.30583","volume":"69","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Kory, N., BasuRay, S., Cohen, J. C. & Hobbs, H. H. PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice. Hepatology 69, 2427\u20132441, https:\/\/doi.org\/10.1002\/hep.30583 (2019).","journal-title":"Hepatology"},{"key":"61473_CR26","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s42255-019-0066-3","volume":"1","author":"A Yang","year":"2019","unstructured":"Yang, A., Mottillo, E. P., Mladenovic-Lucas, L., Zhou, L. & Granneman, J. G. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes. Nat. Metab. 1, 560\u2013569, https:\/\/doi.org\/10.1038\/s42255-019-0066-3 (2019).","journal-title":"Nat. Metab."},{"key":"61473_CR27","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461\u20131465 (2008).","journal-title":"Nat. Genet."},{"key":"61473_CR28","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","volume":"50","author":"S Sookoian","year":"2009","unstructured":"Sookoian, S. et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J. Lipid Res. 50, 2111\u20132116, https:\/\/doi.org\/10.1194\/jlr.P900013-JLR200 (2009).","journal-title":"J. Lipid Res."},{"key":"61473_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng.488","volume":"42","author":"C Tian","year":"2010","unstructured":"Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G. & Hinds, D. A. Variant in PNPLA3 is associated with alcoholic liver disease. Nat. Genet. 42, 21\u201323, https:\/\/doi.org\/10.1038\/ng.488 (2010).","journal-title":"Nat. Genet."},{"key":"61473_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.dld.2012.12.006","volume":"45","author":"L Valenti","year":"2013","unstructured":"Valenti, L., Dongiovanni, P., Ginanni Corradini, S., Burza, M. A. & Romeo, S. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease. Dig. Liver Dis. 45, 619\u2013624, https:\/\/doi.org\/10.1016\/j.dld.2012.12.006 (2013).","journal-title":"Dig. Liver Dis."},{"key":"61473_CR31","doi-asserted-by":"publisher","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","volume":"7","author":"EK Speliotes","year":"2011","unstructured":"Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324, https:\/\/doi.org\/10.1371\/journal.pgen.1001324 (2011).","journal-title":"PLoS Genet."},{"key":"61473_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina, J. et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46, 352\u2013356, https:\/\/doi.org\/10.1038\/ng.2901 (2014).","journal-title":"Nat. Genet."},{"key":"61473_CR33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jhep.2019.03.026","volume":"71","author":"L Youssefian","year":"2019","unstructured":"Youssefian, L. et al. Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations. J. Hepatol. 71, 366\u2013370, https:\/\/doi.org\/10.1016\/j.jhep.2019.03.026 (2019).","journal-title":"J. Hepatol."},{"key":"61473_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jcmgh.2015.05.005","volume":"1","author":"L Maroni","year":"2015","unstructured":"Maroni, L. et al. Functional and structural features of cholangiocytes in health and disease. Cell Mol. Gastroenterol. Hepatol. 1, 368\u2013380, https:\/\/doi.org\/10.1016\/j.jcmgh.2015.05.005 (2015).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"61473_CR35","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","volume":"127","author":"KN Lazaridis","year":"2004","unstructured":"Lazaridis, K. N., Strazzabosco, M. & Larusso, N. F. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 127, 1565\u20131577 (2004).","journal-title":"Gastroenterology"},{"key":"61473_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1242\/jcs.03330","volume":"120","author":"JR Dutton","year":"2007","unstructured":"Dutton, J. R. et al. Beta cells occur naturally in extrahepatic bile ducts of mice. J. Cell Sci. 120, 239\u2013245, https:\/\/doi.org\/10.1242\/jcs.03330 (2007).","journal-title":"J. Cell Sci."},{"key":"61473_CR37","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/hep.22381","volume":"48","author":"F Geisler","year":"2008","unstructured":"Geisler, F. et al. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 48, 607\u2013616, https:\/\/doi.org\/10.1002\/hep.22381 (2008).","journal-title":"Hepatology"},{"key":"61473_CR38","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/hep.23431","volume":"51","author":"EE Sparks","year":"2010","unstructured":"Sparks, E. E., Huppert, K. A., Brown, M. A., Washington, M. K. & Huppert, S. S. Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice. Hepatology 51, 1391\u20131400, https:\/\/doi.org\/10.1002\/hep.23431 (2010).","journal-title":"Hepatology"},{"key":"61473_CR39","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1128\/MCB.01384-13","volume":"34","author":"K Taguchi","year":"2014","unstructured":"Taguchi, K. et al. Nrf2 enhances cholangiocyte expansion in Pten-deficient livers. Mol. Cell Biol. 34, 900\u2013913, https:\/\/doi.org\/10.1128\/MCB.01384-13 (2014).","journal-title":"Mol. Cell Biol."},{"key":"61473_CR40","doi-asserted-by":"publisher","first-page":"E2862","DOI":"10.1073\/pnas.1618291114","volume":"114","author":"M Pyzik","year":"2017","unstructured":"Pyzik, M. et al. Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury. Proc. Natl Acad. Sci. USA 114, E2862\u2013E2871, https:\/\/doi.org\/10.1073\/pnas.1618291114 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"61473_CR41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/hep.30270","volume":"69","author":"JO Russell","year":"2019","unstructured":"Russell, J. O. et al. Hepatocyte-Specific beta-Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes. Hepatology 69, 742\u2013759, https:\/\/doi.org\/10.1002\/hep.30270 (2019).","journal-title":"Hepatology"},{"key":"61473_CR42","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1096\/fj.201801976R","volume":"33","author":"EP Newberry","year":"2019","unstructured":"Newberry, E. P. et al. Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury. FASEB J. 33, 4610\u20134625, https:\/\/doi.org\/10.1096\/fj.201801976R (2019).","journal-title":"FASEB J."},{"key":"61473_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/hep.24338","volume":"54","author":"JW Wu","year":"2011","unstructured":"Wu, J. W. et al. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology 54, 122\u2013132 (2011).","journal-title":"Hepatology"},{"key":"61473_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jhep.2012.10.011","volume":"58","author":"SP O\u2019Hara","year":"2013","unstructured":"O\u2019Hara, S. P., Tabibian, J. H., Splinter, P. L. & LaRusso, N. F. The dynamic biliary epithelia: molecules, pathways, and disease. J. Hepatol. 58, 575\u2013582, https:\/\/doi.org\/10.1016\/j.jhep.2012.10.011 (2013).","journal-title":"J. Hepatol."},{"key":"61473_CR45","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1194\/jlr.M089771","volume":"59","author":"B Kien","year":"2018","unstructured":"Kien, B. et al. ABHD5 stimulates PNPLA1-mediated omega-O-acylceramide biosynthesis essential for a functional skin permeability barrier. J. Lipid Res. 59, 2360\u20132367, https:\/\/doi.org\/10.1194\/jlr.M089771 (2018).","journal-title":"J. Lipid Res."},{"key":"61473_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jdermsci.2018.11.005","volume":"92","author":"Y Ohno","year":"2018","unstructured":"Ohno, Y., Nara, A., Nakamichi, S. & Kihara, A. Molecular mechanism of the ichthyosis pathology of Chanarin-Dorfman syndrome: Stimulation of PNPLA1-catalyzed omega-O-acylceramide production by ABHD5. J. Dermatol. Sci. 92, 245\u2013253, https:\/\/doi.org\/10.1016\/j.jdermsci.2018.11.005 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"61473_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/ng.1056","volume":"44","author":"A Grall","year":"2012","unstructured":"Grall, A. et al. PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans. Nat. Genet. 44, 140\u2013147, https:\/\/doi.org\/10.1038\/ng.1056 (2012).","journal-title":"Nat. Genet."},{"key":"61473_CR48","doi-asserted-by":"publisher","unstructured":"Wang, Y., Kory, N., BasuRay, S., Cohen, J. C. & Hobbs, H. H. PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice. Hepatology, https:\/\/doi.org\/10.1002\/hep.30583 (2019).","DOI":"10.1002\/hep.30583"},{"key":"61473_CR49","doi-asserted-by":"publisher","first-page":"18438","DOI":"10.1074\/jbc.M114.628958","volume":"290","author":"P Hofer","year":"2015","unstructured":"Hofer, P. et al. Fatty Acid-binding Proteins Interact with Comparative Gene Identification-58 Linking Lipolysis with Lipid Ligand Shuttling. J. Biol. Chem. 290, 18438\u201318453, https:\/\/doi.org\/10.1074\/jbc.M114.628958 (2015).","journal-title":"J. Biol. Chem."},{"key":"61473_CR50","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s42255-019-0138-4","volume":"1","author":"ZH Jebessa","year":"2019","unstructured":"Jebessa, Z. H. et al. The lipid droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4. Nat. Metab. 1, 1157\u20131167, https:\/\/doi.org\/10.1038\/s42255-019-0138-4 (2019).","journal-title":"Nat. Metab."},{"key":"61473_CR51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","volume":"4","author":"M Mari","year":"2006","unstructured":"Mari, M. et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 4, 185\u2013198 (2006).","journal-title":"Cell Metab."},{"key":"61473_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","volume":"175","author":"JY Kim","year":"2018","unstructured":"Kim, J. Y. et al. ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P. Cell 175, 133\u2013145 e115, https:\/\/doi.org\/10.1016\/j.cell.2018.08.020 (2018).","journal-title":"Cell"},{"key":"61473_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jhep.2013.11.007","volume":"60","author":"LM Pawella","year":"2014","unstructured":"Pawella, L. M. et al. Perilipin discerns chronic from acute hepatocellular steatosis. J. Hepatol. 60, 633\u2013642, https:\/\/doi.org\/10.1016\/j.jhep.2013.11.007 (2014).","journal-title":"J. Hepatol."},{"key":"61473_CR54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.5551\/jat.2055","volume":"16","author":"H Fujii","year":"2009","unstructured":"Fujii, H. et al. Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. J. Atheroscler. Thromb. 16, 893\u2013901 (2009).","journal-title":"J. Atheroscler. Thromb."},{"key":"61473_CR55","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/hep.22268","volume":"47","author":"BK Straub","year":"2008","unstructured":"Straub, B. K., Stoeffel, P., Heid, H., Zimbelmann, R. & Schirmacher, P. Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis. Hepatology 47, 1936\u20131946 (2008).","journal-title":"Hepatology"},{"key":"61473_CR56","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1152\/physiolgenomics.00045.2012","volume":"44","author":"Y Imai","year":"2012","unstructured":"Imai, Y. et al. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression. Physiol. Genomics 44, 1125\u20131131, https:\/\/doi.org\/10.1152\/physiolgenomics.00045.2012 (2012).","journal-title":"Physiol. Genomics"},{"key":"61473_CR57","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1053\/j.gastro.2007.02.046","volume":"132","author":"Y Imai","year":"2007","unstructured":"Imai, Y. et al. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. Gastroenterology 132, 1947\u20131954, https:\/\/doi.org\/10.1053\/j.gastro.2007.02.046 (2007).","journal-title":"Gastroenterology"},{"key":"61473_CR58","doi-asserted-by":"publisher","first-page":"G726","DOI":"10.1152\/ajpgi.00436.2015","volume":"310","author":"CP Najt","year":"2016","unstructured":"Najt, C. P. et al. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol 310, G726\u2013738, https:\/\/doi.org\/10.1152\/ajpgi.00436.2015 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"61473_CR59","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1128\/MCB.26.3.1063-1076.2006","volume":"26","author":"BH Chang","year":"2006","unstructured":"Chang, B. H. et al. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol. Cell Biol. 26, 1063\u20131076 (2006).","journal-title":"Mol. Cell Biol."},{"key":"61473_CR60","doi-asserted-by":"publisher","first-page":"R996","DOI":"10.1152\/ajpregu.00177.2011","volume":"302","author":"RM Carr","year":"2012","unstructured":"Carr, R. M. et al. Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol 302, R996\u20131003, https:\/\/doi.org\/10.1152\/ajpregu.00177.2011 (2012).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"key":"61473_CR61","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/hep.27409","volume":"61","author":"C Wang","year":"2015","unstructured":"Wang, C. et al. Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis. Hepatology 61, 870\u2013882, https:\/\/doi.org\/10.1002\/hep.27409 (2015).","journal-title":"Hepatology"},{"key":"61473_CR62","doi-asserted-by":"publisher","first-page":"E770","DOI":"10.1152\/ajpendo.00523.2012","volume":"304","author":"W Chen","year":"2013","unstructured":"Chen, W. et al. Inactivation of Plin4 downregulates Plin5 and reduces cardiac lipid accumulation in mice. Am. J. Physiol. Endocrinol. Metab. 304, E770\u2013779, https:\/\/doi.org\/10.1152\/ajpendo.00523.2012 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"61473_CR63","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1242\/jcs.104943","volume":"125","author":"K Hsieh","year":"2012","unstructured":"Hsieh, K. et al. Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-ester-specific intracellular lipid storage droplets. J. Cell Sci. 125, 4067\u20134076, https:\/\/doi.org\/10.1242\/jcs.104943 (2012).","journal-title":"J. Cell Sci."},{"key":"61473_CR64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","volume":"6","author":"M Monetti","year":"2007","unstructured":"Monetti, M. et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 6, 69\u201378 (2007).","journal-title":"Cell Metab."},{"key":"61473_CR65","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nm.2744","volume":"18","author":"Z Sun","year":"2012","unstructured":"Sun, Z. et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 18, 934\u2013942, https:\/\/doi.org\/10.1038\/nm.2744 (2012).","journal-title":"Nat. Med."},{"key":"61473_CR66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/oby.20426","volume":"22","author":"AL Schneider","year":"2014","unstructured":"Schneider, A. L., Lazo, M., Selvin, E. & Clark, J. M. Racial differences in nonalcoholic fatty liver disease in the U.S. population. Obes. 22, 292\u2013299, https:\/\/doi.org\/10.1002\/oby.20426 (2014).","journal-title":"Obes."},{"key":"61473_CR67","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich, N. E. et al. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol. 16, 198\u2013210 e192, https:\/\/doi.org\/10.1016\/j.cgh.2017.09.041 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"61473_CR68","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1172\/JCI30060","volume":"117","author":"RE Temel","year":"2007","unstructured":"Temel, R. E. et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J. Clin. Invest. 117, 1968\u20131978 (2007).","journal-title":"J. Clin. Invest."},{"key":"61473_CR69","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1194\/jlr.M006353","volume":"51","author":"L Jia","year":"2010","unstructured":"Jia, L. et al. Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis. J. Lipid Res. 51, 3135\u20133144 (2010).","journal-title":"J. Lipid Res."},{"key":"61473_CR70","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1194\/jlr.M700279-JLR200","volume":"48","author":"JM Brown","year":"2007","unstructured":"Brown, J. M. et al. CGI-58 facilitates the mobilization of cytoplasmic triglyceride for lipoprotein secretion in hepatoma cells. J. Lipid Res. 48, 2295\u20132305 (2007).","journal-title":"J. Lipid Res."},{"key":"61473_CR71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-4939-1862-1_10","volume":"1239","author":"L Cong","year":"2015","unstructured":"Cong, L. & Zhang, F. Genome engineering using CRISPR-Cas9 system. Methods Mol. Biol. 1239, 197\u2013217, https:\/\/doi.org\/10.1007\/978-1-4939-1862-1_10 (2015).","journal-title":"Methods Mol. Biol."},{"key":"61473_CR72","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.2337\/db12-1311","volume":"62","author":"N Kumashiro","year":"2013","unstructured":"Kumashiro, N. et al. Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance. Diabetes 62, 2183\u20132194, https:\/\/doi.org\/10.2337\/db12-1311 (2013).","journal-title":"Diabetes"},{"key":"61473_CR73","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.2337\/db08-0144","volume":"57","author":"N Kumashiro","year":"2008","unstructured":"Kumashiro, N. et al. Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance. Diabetes 57, 2083\u20132091, https:\/\/doi.org\/10.2337\/db08-0144 (2008).","journal-title":"Diabetes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61473-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:07:57Z","timestamp":1670314077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61473-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61473"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61473-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,13]]},"assertion":[{"value":"5 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4701"}}